BioNJ welcomes our new Preferred Members

BioNJ welcomes our new Preferred Members:

inVentiv Health

inVentiv Health is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health’s client roster is comprised of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payer companies, including all top 20 global pharmaceutical manufacturers.

Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation (NPC) researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions including central nervous system disorders, organ transplantation, cardio-vascular diseases, dermatological disorders, respiratory disorders, cancer and arthritis.

Rutgers, The State University of New Jersey

The New Jersey university that teaches future healthcare professionals in medicine, dentistry, allied health and nursing, as well as future scientists in the life science profession. As the nation’s largest university of its kind, the university has a wide system of healthcare, health sciences education and biomedical research and is dedicated to the pursuit of excellence.